{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:43:38Z","timestamp":1790289818944,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["14-50-00060"],"award-info":[{"award-number":["14-50-00060"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006261","name":"Taif University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.bmcl.2017.05.052","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T16:01:32Z","timestamp":1495036892000},"page":"3081-3086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of the antiprotozoan properties of 5\u2032-norcarbocyclic pyrimidine nucleosides"],"prefix":"10.1016","volume":"27","author":[{"given":"Khalid J.","family":"Alzahrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena S.","family":"Matyugina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia L.","family":"Khandazhinskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei N.","family":"Kochetkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Seley-Radtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry P. de","family":"Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2017.05.052_b0005","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(03)14694-6","article-title":"The trypanosomiases","volume":"362","author":"Barrett","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2017.05.052_b0010","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1017\/S0031182016001268","article-title":"The animal trypanosomiases and their chemotherapy: a review","volume":"143","author":"Giordani","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.bmcl.2017.05.052_b0015","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2017.05.052_b0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2007.02.004","article-title":"Drugs and drug resistance in African trypanosomiasis","volume":"10","author":"Delespaux","year":"2007","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.bmcl.2017.05.052_b0025","doi-asserted-by":"crossref","first-page":"10611","DOI":"10.1016\/S0040-4020(01)89258-9","article-title":"Synthesis of carbocyclic nucleosides","volume":"50","author":"Agrofoglio","year":"1994","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2017.05.052_b0030","first-page":"s65","article-title":"Structures of neplanocins, new antitumor antibiotics","author":"Hayashi","year":"1980","journal-title":"Nucleic Acids Symp Ser"},{"key":"10.1016\/j.bmcl.2017.05.052_b0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7164\/antibiotics.21.255","article-title":"Streptomyces citricolor nov. sp. and a new antibiotic, aristeromycin","volume":"21","author":"Kusaka","year":"1968","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.bmcl.2017.05.052_b0040","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1070\/RC2012v081n08ABEH004314","article-title":"Carbocyclic nucleoside analogues: classification, target enzymes, mechanisms of action and synthesis","volume":"81","author":"Matyugina","year":"2012","journal-title":"Russian Chem Rev"},{"key":"10.1016\/j.bmcl.2017.05.052_b0045","series-title":"Advances in antiviral drug design","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1075-8593(96)80104-3","article-title":"Carbocyclic nucleosides","volume":"Vol. 2","author":"Marquez","year":"1996"},{"key":"10.1016\/j.bmcl.2017.05.052_b0050","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/jm00035a020","article-title":"An epimer of 5'-noraristeromycin and its antiviral properties","volume":"37","author":"Siddiqi","year":"1994","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0055","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0960-894X(01)81249-X","article-title":"(+\/-)-7-Deazaaristeromycin lacking the hydroxylmethyl substituent","volume":"3","author":"Siddiqi","year":"1993","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2017.05.052_b0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bmc.2012.09.051","article-title":"C-3 halo and 3-methyl substituted 5'-nor-3-deazaaristeromycins: synthesis and antiviral properties","volume":"21","author":"Liu","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0065","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1128\/AAC.41.8.1658","article-title":"Synthesis and antitrypanosomal activities of a series of 7-deaza-5'-noraristeromycin derivatives with variations in the cyclopentyl ring substituents","volume":"41","author":"Seley","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2017.05.052_b0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/095632020101200205","article-title":"5'-norcarbocyclic 5'-deoxy-5'-(isobutylthio)adenosine and a 2',3'-dideoxy-2',3'-didehydro derivative","volume":"12","author":"Das","year":"2001","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.bmcl.2017.05.052_b0075","article-title":"Inhibition of measles virus replication by 5'-nor carbocyclic nucleoside analogs","volume":"46","author":"Barnard","year":"2000","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2017.05.052_b0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/095632020101200405","article-title":"Inhibition of measles virus replication by 5'-nor carbocyclic adenosine analogues","volume":"12","author":"Barnard","year":"2001","journal-title":"Antivir Chem Chemoth"},{"key":"10.1016\/j.bmcl.2017.05.052_b0085","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1080\/07328319908044851","article-title":"The synthesis of carbocyclic 5'-nor thymidine and an isomer as oligonucleotide monomers","volume":"18","author":"Hegde","year":"1999","journal-title":"Nucleos Nucleot"},{"key":"10.1016\/j.bmcl.2017.05.052_b0090","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/jhet.5570370558","article-title":"Carbocyclic 5'-norcytidine (5'-noroarbodine)","volume":"37","author":"Hegde","year":"2000","journal-title":"J Heterocyclic Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/15257770008033008","article-title":"Carbocyclic 5'-noruridine","volume":"19","author":"Hegde","year":"2000","journal-title":"Nucleos Nucleot Nucl"},{"key":"10.1016\/j.bmcl.2017.05.052_b0100","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1021\/jo972078c","article-title":"5'-Amino-5'-deoxy-5'-noraristeromycin","volume":"63","author":"Hegde","year":"1998","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0105","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1134\/S1068162010060099","article-title":"Synthesis and antiviral evaluation against the Vaccinia virus of new N-1-oxide analogs of 5'-noraristeromycin","volume":"36","author":"Matyugina","year":"2010","journal-title":"Russ J Bioorg Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0110","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1039\/c3md00036b","article-title":"5'-Nor carbocyclic nucleosides: unusual nonnucleoside inhibitors of HIV-1 reverse transcriptase","volume":"4","author":"Matyugina","year":"2013","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bmcl.2017.05.052_b0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jhet.5570360144","article-title":"7-deaza-5'-noraristeromycin derivatives resembling L-toyocamycin and L-sangivamycin","volume":"36","author":"Seley","year":"1999","journal-title":"J Heterocyclic Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0968-0896(98)00036-4","article-title":"The importance of the 4'-hydroxyl hydrogen for the anti-trypanosomal and antiviral properties of (+)-5'-noraristeromycin and two 7-deaza analogues","volume":"6","author":"Seley","year":"1998","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0125","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1080\/07328319708002560","article-title":"A 5'-noraristeromycin enantiomer with activity towards hepatitis B virus","volume":"16","author":"Seley","year":"1997","journal-title":"Nucleos Nucleot"},{"key":"10.1016\/j.bmcl.2017.05.052_b0130","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1021\/jm980038a","article-title":"Does the anti-hepatitis B virus activity of (+)-5'-noraristeromycin exist in its 4'-epimer and 4'-deoxygenated derivatives?","volume":"41","author":"Seley","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0135","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1021\/jm9605039","article-title":"(+)-7-deaza-5'-noraristeromycin as an anti-trypanosomal agent","volume":"40","author":"Seley","year":"1997","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0140","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1021\/jm9606148","article-title":"Synthesis and anti-trypanosomal activity of various 8-aza-7-deaza-5'-noraristeromycin derivatives","volume":"40","author":"Seley","year":"1997","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0145","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1021\/jo970515h","article-title":"Methylated derivative of 5'-noraristeromycin","volume":"62","author":"Seley","year":"1997","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0150","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1039\/c1md00094b","article-title":"Carbocyclic 5'-nor \u201creverse\u201d fleximers. Design, synthesis, and preliminary biological activity","volume":"2","author":"Zimmermann","year":"2011","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bmcl.2017.05.052_b0155","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1080\/15257770.2014.917671","article-title":"The 5'-nor aristeromycin analogues of 5'-deoxy-5'-methylthioadenosine and 5'-deoxy-thiophenyladenosine","volume":"33","author":"Das","year":"2014","journal-title":"Nucleos Nucleot Nucl"},{"key":"10.1016\/j.bmcl.2017.05.052_b0160","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1021\/jo00075a052","article-title":"Synthesis of (+)-5'-nor-2'-deoxyaristeromycin and (-)-5'-nor-3'-deoxyaristeromycin","volume":"58","author":"Koga","year":"1993","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0165","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1021\/jm00090a007","article-title":"(+\/-)-Carbocyclic 5'-nor-2'-deoxyguanosine and related purine derivatives - synthesis and antiviral properties","volume":"35","author":"Patil","year":"1992","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0170","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/jhet.5570280351","article-title":"(+\/-)-5'-nor-Ribofuranoside carbocyclic guanosine","volume":"28","author":"Patil","year":"1991","journal-title":"J Heterocyclic Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0175","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1081\/SCC-100105336","article-title":"A protected form of (1S,2R,3S,4R)-4-aminocyclopentane-1,2,3-triol, a useful precursor to 5'-nor carbocyclic nucleosides","volume":"31","author":"Rajappan","year":"2001","journal-title":"Synth Commun"},{"key":"10.1016\/j.bmcl.2017.05.052_b0180","doi-asserted-by":"crossref","first-page":"9889","DOI":"10.1016\/S0040-4020(02)01195-X","article-title":"A flexible synthesis of carbanucleosides and 5'-nor-1'-homo carbanucleosides from a common precursor","volume":"58","author":"Rajappan","year":"2002","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2017.05.052_b0185","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1081\/NCN-120026401","article-title":"5'-nor carbocyclic ribavirin","volume":"22","author":"Tuncbilek","year":"2003","journal-title":"Nucleos Nucleot Nucl"},{"key":"10.1016\/j.bmcl.2017.05.052_b0190","doi-asserted-by":"crossref","first-page":"21200","DOI":"10.3390\/molecules191221200","article-title":"Design and synthesis of a series of truncated neplanocin fleximers","volume":"19","author":"Zimmermann","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2017.05.052_b0195","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s11172-014-0551-5","article-title":"5'-Norcarbocyclic nucleoside analogs","volume":"63","author":"Matyugina","year":"2014","journal-title":"Russian Chem B"},{"key":"10.1016\/j.bmcl.2017.05.052_b0200","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1039\/c3md00225j","article-title":"Structure-activity evaluation of new uracil-based non-nucleoside inhibitors of HIV reverse transcriptase","volume":"4","author":"Matyugina","year":"2013","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bmcl.2017.05.052_b0205","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/cbdd.12603","article-title":"5-Arylaminouracil derivatives: new inhibitors of Mycobacterium tuberculosis","volume":"86","author":"Matyugina","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmcl.2017.05.052_b0210","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1081\/NCN-200027660","article-title":"Selective transport of a new class of purine antimetabolites by the protozoan parasite Trypanosoma brucei","volume":"23","author":"Wallace","year":"2004","journal-title":"Nucleos Nucleot Nucl"},{"key":"10.1016\/j.bmcl.2017.05.052_b0215","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1073\/pnas.111139498","article-title":"Trypanosoma brucei CTP synthetase: a target for the treatment of African sleeping sickness","volume":"98","author":"Hofer","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmcl.2017.05.052_b0220","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2958.2008.06305.x","article-title":"Chemical and genetic validation of dihydrofolate reductase-thymidylate synthase as a drug target in African trypanosomes","volume":"69","author":"Sienkiewicz","year":"2008","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bmcl.2017.05.052_b0225","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1016\/j.biocel.2008.06.009","article-title":"Depletion of dimeric all-alpha dUTPase induces DNA strand breaks and impairs cell cycle progression in Trypanosoma brucei","volume":"40","author":"Castillo-Acosta","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.bmcl.2017.05.052_b0230","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/mmi.13467","article-title":"Cell cycle regulation and novel structural features of thymidine kinase, an essential enzyme in Trypanosoma brucei","volume":"102","author":"Valente","year":"2016","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bmcl.2017.05.052_b0235","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1124\/mol.112.082321","article-title":"Pyrimidine salvage in Trypanosoma brucei bloodstream forms and the trypanocidal action of halogenated pyrimidines","volume":"83","author":"Ali","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmcl.2017.05.052_b0240","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijpddr.2017.04.003","article-title":"Functional and genetic evidence that nucleoside transport is highly conserved in Leishmania species: implications for pyrimidine-based chemotherapy","volume":"7","author":"Alzahrani","year":"2017","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.bmcl.2017.05.052_b0245","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pt.2016.11.003","article-title":"Exploiting knowledge on Leishmania drug resistance to support the quest for new drugs","volume":"33","author":"Hefnawy","year":"2017","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bmcl.2017.05.052_b0250","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1515\/hc-2015-0160","article-title":"5'-Norcarbocyclic analogues of furano 2,3-d pyrimidine nucleosides","volume":"21","author":"Matyugina","year":"2015","journal-title":"Heterocyclic Commun"},{"key":"10.1016\/j.bmcl.2017.05.052_b0255","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.bcp.2008.07.035","article-title":"7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities","volume":"76","author":"Al Safarjalani","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2017.05.052_b0260","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.bcp.2010.06.001","article-title":"Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: biological activities and selective toxicities","volume":"80","author":"Al Safarjalani","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2017.05.052_b0265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cbpb.2015.06.006","article-title":"Kinetic mechanism of Toxoplasma gondii adenosine kinase and the highly efficient utilization of adenosine","volume":"188","author":"Naguib","year":"2015","journal-title":"Comp Biochem Physiol B: Biochem Mol Biol"},{"key":"10.1016\/j.bmcl.2017.05.052_b0270","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1124\/mol.106.031351","article-title":"Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in African trypanosomes","volume":"71","author":"Bridges","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmcl.2017.05.052_b0275","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0166-6851(99)00206-6","article-title":"Further evidence for a link between melarsoprol resistance and P2 transporter function in African trypanosomes","volume":"106","author":"De Koning","year":"2000","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmcl.2017.05.052_b0280","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1128\/AAC.00425-07","article-title":"2, N-6-disubstituted adenosine analogs with antitrypanosomal and antimalarial activities","volume":"51","author":"Rodenko","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2017.05.052_b0285","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ab.2008.07.036","article-title":"Propidium iodide-based methods for monitoring drug action in the kinetoplastidae: comparison with the Alamar Blue assay","volume":"382","author":"Gould","year":"2008","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0290","series-title":"Trypanosomatid Diseases","first-page":"335","article-title":"Transporters in anti-parasitic drug development and resistance","author":"Delespaux","year":"2013"},{"key":"10.1016\/j.bmcl.2017.05.052_b0295","first-page":"1162","article-title":"Adenosine transporters in bloodstream forms of Trypanosoma brucei brucei: substrate recognition motifs and affinity for trypanocidal drugs","volume":"56","author":"De Koning","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmcl.2017.05.052_b0300","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/mmi.12979","article-title":"Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein","volume":"96","author":"Munday","year":"2015","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bmcl.2017.05.052_b0305","doi-asserted-by":"crossref","first-page":"34028","DOI":"10.1074\/jbc.M109.049726","article-title":"Predictive computational models of substrate binding by a nucleoside transporter","volume":"284","author":"Collar","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0310","doi-asserted-by":"crossref","first-page":"e58034","DOI":"10.1371\/journal.pone.0058034","article-title":"Pyrimidine biosynthesis is not an essential function for Trypanosoma brucei bloodstream forms","volume":"8","author":"Ali","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2017.05.052_b0315","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1124\/mol.63.4.814","article-title":"A Leishmania major nucleobase transporter responsible for allopurinol uptake is a functional homolog of the Trypanosoma brucei H2 transporter","volume":"63","author":"Al-Salabi","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmcl.2017.05.052_b0320","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S0031182004006626","article-title":"Identification of the first pyrimidine nucleobase transporter in Leishmania: similarities with the Trypanosoma brucei U1 transporter and antileishmanial activity of uracil analogues","volume":"130","author":"Papageorgiou","year":"2005","journal-title":"Parasitology"},{"key":"10.1016\/j.bmcl.2017.05.052_b0325","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1124\/mol.104.010298","article-title":"Molecular pharmacology of adenosine transport in Trypanosoma brucei: P1\/P2 revisited","volume":"68","author":"Geiser","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmcl.2017.05.052_b0330","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1128\/AAC.01787-09","article-title":"Evaluation of nucleoside hydrolase inhibitors for treatment of African trypanosomiasis","volume":"54","author":"Berg","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2017.05.052_b0335","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1021\/jm401530a","article-title":"Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis","volume":"56","author":"Vodnala","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.05.052_b0340","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.femsre.2005.03.004","article-title":"Purine and pyrimidine transport in pathogenic protozoa: From biology to therapy","volume":"29","author":"De Koning","year":"2005","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.bmcl.2017.05.052_b0345","doi-asserted-by":"crossref","first-page":"e1006010","DOI":"10.1371\/journal.ppat.1006010","article-title":"Pyrimidine salvage enzymes are essential for de novo biosynthesis of deoxypyrimidine nucleotides in Trypanosoma brucei","volume":"12","author":"Leija","year":"2016","journal-title":"PLoS Pathog"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17305334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17305334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:17:44Z","timestamp":1760771864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X17305334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":69,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0960894X17305334"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.05.052","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the antiprotozoan properties of 5\u2032-norcarbocyclic pyrimidine nucleosides","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.05.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}